Add BrightSurf on Google Email

University at Albany, SUNY


Chemists design candidate drug against diabetes

A new small molecule drug, RAGE406R, has been developed to disrupt a key cellular pathway responsible for chronic inflammation and associated complications in patients with diabetes. The breakthrough could offer a new therapeutic option for stopping the harmful effects of both type 1 and type 2 diabetes at the source.

SourceUniversity at Albany, SUNY·JournalCell Chemical Biology·TypeExperimental study·DateOct 29, 2025

New study identifies key ingredients to expanding dental care in the safety net

A new study from the University at Albany's Oral Health Workforce Research Center analyzed data on Federally Qualified Health Centers and found that capacity-building steps such as investing in skilled providers and improving infrastructure enable more people to access essential health services. The study identified three leading facto...

SourceUniversity at Albany, SUNY·JournalJournal of Public Health Dentistry·TypeData/statistical analysis·DateJul 8, 2025

Study links lack of oral health care with complications during pregnancy

A new study found that pregnant women who received preventive oral health care had a lower risk of developing gestational diabetes and hypertensive disorders. The research highlights the importance of integrating oral health education and services into maternal healthcare, particularly in underserved populations.

SourceUniversity at Albany, SUNY·JournalThe Journal of the American Dental Association·TypeData/statistical analysis·DateMar 20, 2025